Biotechnology
New patent expiration for the drug Astrazeneca Ab BYDUREON PEN
New patent expiration for the drug Astrazeneca Ab BYDUREON PEN
Annual Drug Patent Expiration for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and included in one NDA. It is available from a single supplier. There are twenty two…
Post New patent expiration for the drug Astrazeneca Ab BYDUREON PEN appeared the first time DrugPatentWatch – Making Better Decisions.
Comments are closed.
